Mevis Medical Solutions AG
Mevis Medical Solutions AG develops and sells software and hardware solutions for medical imaging and diagnostics, primarily serving the healthcare industry.
Business. Mevis Medical Solutions AG (M3VGN.DE) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Germany and is listed on the Xetra exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Mevis Medical Solutions AG (M3VGN.DE) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Germany and is listed on the Xetra exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Mevis Medical Solutions AG has a basic and diluted share count of 1,820,000 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
The company reported a last actual EPS of 3.94 EUR and revenue of 16,758,000 EUR, suggesting a relatively strong profitability position. While no direct comparison to industry medians is available, the EPS and revenue figures indicate a solid performance for a firm in the Advanced Medical Equipment & Technology industry.
Mevis Medical Solutions AG operates in a single business segment focused on medical imaging and diagnostics. The company's geographic exposure is not disclosed in the available data, but its primary market is likely concentrated in Europe, given its listing on the German stock exchange.
The company's growth trajectory is not explicitly outlined in the available data, but the reported revenue and EPS figures suggest a stable or growing business. No specific growth rates or future projections are provided in the input data.
The risk assessment indicates a low dilution risk, but the liquidity risk could not be evaluated due to missing balance-sheet data. No dilution sources are explicitly identified in the input data, and no recent events such as filings or transcripts are provided to assess potential dilution pressures.
No recent events, such as filings or transcripts, are provided in the input data to inform the company's current strategic or operational developments. The absence of such information limits the ability to assess recent changes in the company's business model or risk profile.
- Mevis Medical Solutions AG operates in the Advanced Medical Equipment & Technology industry with a strong focus on medical imaging and diagnostics.
- The company has a basic and diluted share count of 1,820,000, indicating no immediate dilution pressure.
- The last actual EPS of 3.94 EUR and revenue of 16,758,000 EUR suggest a solid profitability position.
- The liquidity risk remains unassessed due to missing balance-sheet data and no going-concern language in the source documents.
- The company's geographic exposure is not disclosed, but its listing on the German stock exchange suggests a European market focus.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €16.1M, −5,4% YoY; Operating income −39,0% YoY.
- ▍Revenue €16.1M, −5,4% YoY
- ▍Operating income −39,0% YoY
- ▍Net income −30,6% YoY
- ▍Free cash flow −163,0% YoY
- ▍Net margin 19.7%
Revenue €17.0M, −2,1% YoY; Operating income −10,1% YoY.
- ▍Revenue €17.0M, −2,1% YoY
- ▍Operating income −10,1% YoY
- ▍Net income −7,3% YoY
- ▍Free cash flow +81,5% YoY
- ▍Net margin 26.9%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Mevis Medical Solutions AG Market data — financials · 2026-05-28
- Mevis Medical Solutions AG Market data — analyst estimates · 2026-05-28
Ownership & reference
Leadership
- Kimberley E. HoneysettChairman of the Supervisory Board